Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Int J Mol Sci ; 22(23)2021 Dec 02.
Article in English | MEDLINE | ID: mdl-34884863

ABSTRACT

The ability of NQO2 to increase the production of free radicals under enhanced generation of quinone derivatives of catecholamines is considered to be a component of neurodegenerative disease pathogenesis. The present study aimed to investigate the neuroprotective mechanisms of original NQO2 inhibitor M-11 (2-[2-(3-oxomorpholin-4-il)-ethylthio]-5-ethoxybenzimidazole hydrochloride) in a cellular damage model using NQO2 endogenous substrate adrenochrome (125 µM) and co-substrate BNAH (100 µM). The effects of M-11 (10-100 µM) on the reactive oxygen species (ROS) generation, apoptosis and lesion of nuclear DNA were evaluated using flow cytometry and single-cell gel electrophoresis assay (comet assay). Results were compared with S29434, the reference inhibitor of NQO2. It was found that treatment of HT-22 cells with M-11 results in a decline of ROS production triggered by incubation of cells with NQO2 substrate and co-substrate. Pre-incubation of HT-22 cells with compounds M-11 or S29434 results in a decrease of DNA damage and late apoptotic cell percentage reduction. The obtained results provide a rationale for further development of the M-11 compound as a potential neuroprotective agent.


Subject(s)
Enzyme Inhibitors/pharmacology , Neurons/drug effects , Neuroprotective Agents/pharmacology , Quinone Reductases/antagonists & inhibitors , Adrenochrome/metabolism , Animals , Apoptosis/drug effects , Benzimidazoles/chemistry , Cell Line , DNA Damage , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/chemistry , Hippocampus/cytology , Male , Mice, Inbred ICR , Neurons/metabolism , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/chemistry , Pyridines/pharmacology , Pyrrolizidine Alkaloids/pharmacology , Quinone Reductases/metabolism , Reactive Oxygen Species/metabolism
2.
J Photochem Photobiol B ; 216: 112151, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33581679

ABSTRACT

Photochemoprotection of the skin can be achieved by inhibiting inflammation and oxidative stress, which we tested using Cordia verbenacea extract, a medicinal plant known for its rich content of antioxidant molecules and anti-inflammatory activity. In vitro antioxidant evaluation of Cordia verbenacea leaves ethanolic extract (CVE) presented the following results: ferric reducing antioxidant power (886.32 µM equivalent of Trolox/g extract); IC50 of 19.128 µg/ml for scavenging 2,2-diphenyl-1-picrylhydrazyl; IC50 of 12.48 µg/mL for scavenging 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); decrease of hydroperoxides from linoleic acid (IC50 of 10.20 µg/mL); inhibition of thiobarbituric acid reactive substances (IC50 8.90 µg/mL); iron-chelating ability in bathophenanthroline iron assay (IC50 47.35 µg/mL); chemiluminescence triggered by free radicals in the H2O2/horseradish peroxidase/luminol (IC50 0.286 µg/mL) and xanthine/xanthine oxidase/luminol (IC50 0.42 µg/mL) methods. CVE (10-100 mg per kg, 30 min before and immediately after UVB exposure) treatment was performed by gavage in hairless mice. CVE inhibited skin edema, neutrophil infiltration, and overproduction of MMP-9; reduced levels of TNF-α, IL-1ß, and IL- 6; numbers of skin mast cells, epidermal thickening, number of epidermal apoptotic keratinocytes, and collagen degradation. CVE increased the skin's natural antioxidant defenses as observed by Nrf-2, NAD(P)H quinone oxidoreductase 1, and heme oxygenase 1 mRNA expression enhancement. Furthermore, CVE inhibited lipid peroxidation and superoxide anion production and recovered antioxidant reduced glutathione, catalase activity, and ROS scavenging capacity of the skin. Concluding, CVE downregulates the skin inflammatory and oxidative damages triggered by UVB, demonstrating its potentialities as a therapeutic approach.


Subject(s)
Anti-Inflammatory Agents/chemistry , Antioxidants/chemistry , Cordia/chemistry , Plant Extracts/chemistry , Plant Leaves/chemistry , Protective Agents/chemistry , Animals , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Cytokines/metabolism , Edema/metabolism , Female , Heme Oxygenase-1/metabolism , Humans , Hydrogen Peroxide/chemistry , Linoleic Acid/chemistry , Lipid Peroxidation , Mice, Hairless , NF-E2-Related Factor 2/metabolism , Oxidative Stress/drug effects , Oxidative Stress/radiation effects , Plant Extracts/pharmacology , Protective Agents/pharmacology , Quinone Reductases/metabolism , Skin/radiation effects , Superoxides/metabolism , Ultraviolet Rays
3.
Chembiochem ; 22(6): 949-960, 2021 03 16.
Article in English | MEDLINE | ID: mdl-33080111

ABSTRACT

Hydrogen sulfide (H2 S) is an environmental toxin and a heritage of ancient microbial metabolism that has stimulated new interest following its discovery as a neuromodulator. While many physiological responses have been attributed to low H2 S levels, higher levels inhibit complex IV in the electron transport chain. To prevent respiratory poisoning, a dedicated set of enzymes that make up the mitochondrial sulfide oxidation pathway exists to clear H2 S. The committed step in this pathway is catalyzed by sulfide quinone oxidoreductase (SQOR), which couples sulfide oxidation to coenzyme Q10 reduction in the electron transport chain. The SQOR reaction prevents H2 S accumulation and generates highly reactive persulfide species as products; these can be further oxidized or can modify cysteine residues in proteins by persulfidation. Here, we review the kinetic and structural characteristics of human SQOR, and how its unconventional redox cofactor configuration and substrate promiscuity lead to sulfide clearance and potentially expand the signaling potential of H2 S. This dual role of SQOR makes it a promising target for H2 S-based therapeutics.


Subject(s)
Hydrogen Sulfide/metabolism , Quinone Reductases/metabolism , Catalytic Domain , Electron Transport Complex IV/metabolism , Humans , Hydrogen Sulfide/chemistry , Mitochondria/metabolism , Oxidation-Reduction , Oxidative Phosphorylation , Quinone Reductases/chemistry , Quinone Reductases/classification , Substrate Specificity , Ubiquinone/analogs & derivatives , Ubiquinone/chemistry
4.
J Agric Food Chem ; 68(43): 11975-11986, 2020 Oct 28.
Article in English | MEDLINE | ID: mdl-33054205

ABSTRACT

Garcinia mangostana L. (mangosteen) is a famous tropical fruit that contains a large number of xanthones. Regular consumption of mangosteen may confer health benefits and prevent some diseases, such as malaria. Quinone reductase 2 (QR-2) is a cytosolic enzyme found in human red blood cells, and it is becoming a target for chemoprevention because it is involved in the mechanisms of several diseases, including malaria. To understand whether the xanthones present in mangosteen might inhibit the activity of QR-2, blood samples were collected from rat following the oral administration of mangosteen extract and then incubated with QR-2 followed by UF-HPLC-QTOF/MS analysis to rapidly screen for and identify the QR-2-inhibiting xanthones. A total of 16 xanthones were identified, and six of these (α-mangostin, γ-mangostin, 8-deoxyartanin, 1,3,7-trihydroxy-2,8-di(3-methylbut-2-enyl)xanthone, garcinone E, and 9-hydroxycalabaxanthone) were subjected to QR-2 inhibition assay. γ-Mangostin exhibited the strongest inhibition, achieving an IC50 value of 3.82 ± 0.51 µM. Its interaction with QR-2 was found to involve hydrogen bond and arene-arene interaction as revealed by molecular docking. The present study could provide new insight into the potential application of mangosteen as functional food ingredients for inhibiting the activity of QR-2. However, the extent of daily intake of mangosteen required and the exact contribution of mangosteen to the prevention and treatment of malaria remain subjects of further study.


Subject(s)
Enzyme Inhibitors/pharmacokinetics , Garcinia mangostana/chemistry , Plant Extracts/pharmacokinetics , Quinone Reductases/antagonists & inhibitors , Administration, Oral , Animals , Chromatography, Liquid , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/chemistry , Fruit/chemistry , Humans , Molecular Docking Simulation , Molecular Structure , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Quinone Reductases/chemistry , Quinone Reductases/metabolism , Rats , Rats, Sprague-Dawley , Tandem Mass Spectrometry , Xanthones/administration & dosage , Xanthones/chemistry , Xanthones/pharmacokinetics
5.
J Biol Chem ; 294(32): 12077-12090, 2019 08 09.
Article in English | MEDLINE | ID: mdl-31213529

ABSTRACT

Unlike most other tissues, the colon epithelium is exposed to high levels of H2S derived from gut microbial metabolism. H2S is a signaling molecule that modulates various physiological effects. It is also a respiratory toxin that inhibits complex IV in the electron transfer chain (ETC). Colon epithelial cells are adapted to high environmental H2S exposure as they harbor an efficient mitochondrial H2S oxidation pathway, which is dedicated to its disposal. Herein, we report that the sulfide oxidation pathway enzymes are apically localized in human colonic crypts at the host-microbiome interface, but that the normal apical-to-crypt gradient is lost in colorectal cancer epithelium. We found that sulfide quinone oxidoreductase (SQR), which catalyzes the committing step in the mitochondrial sulfide oxidation pathway and couples to complex III, is a critical respiratory shield against H2S poisoning. H2S at concentrations ≤20 µm stimulated the oxygen consumption rate in colon epithelial cells, but, when SQR expression was ablated, H2S concentrations as low as 5 µm poisoned cells. Mitochondrial H2S oxidation altered cellular bioenergetics, inducing a reductive shift in the NAD+/NADH redox couple. The consequent electron acceptor insufficiency caused uridine and aspartate deficiency and enhanced glutamine-dependent reductive carboxylation. The metabolomic signature of this H2S-induced stress response mapped, in part, to redox-sensitive nodes in central carbon metabolism. Colorectal cancer tissues and cell lines appeared to counter the growth-restricting effects of H2S by overexpressing sulfide oxidation pathway enzymes. Our findings reveal an alternative mechanism for H2S signaling, arising from alterations in mitochondrial bioenergetics that drive metabolic reprogramming.


Subject(s)
Energy Metabolism , Hydrogen Sulfide/metabolism , Mitochondria/metabolism , Cell Line , Cell Proliferation/drug effects , Colon/cytology , Colon/metabolism , Colon/pathology , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Cysteine/chemistry , Cysteine/metabolism , Energy Metabolism/drug effects , Humans , Hydrogen Sulfide/chemistry , Hydrogen Sulfide/pharmacology , NAD/chemistry , Oxidation-Reduction , Oxygen Consumption/drug effects , Quinone Reductases/antagonists & inhibitors , Quinone Reductases/genetics , Quinone Reductases/metabolism , RNA Interference , RNA, Small Interfering/metabolism
6.
Oxid Med Cell Longev ; 2018: 7616852, 2018.
Article in English | MEDLINE | ID: mdl-29743984

ABSTRACT

Oxidative stress and inflammation undoubtedly contribute to the pathogenesis of many human diseases. The nuclear transcription factor erythroid 2-related factor (Nrf2) and the nuclear factor κB (NF-κB) play central roles in regulation of oxidative stress and inflammation and thus are targets for developing agents against oxidative stress- and inflammation-related diseases. Our previous study indicated that the EtOH extract of Litsea garrettii protected human bronchial epithelial cells against oxidative insult via the activation of Nrf2. In the present study, a systemic phytochemical investigation of L. garrettii led to the isolation of twenty-one chemical ingredients, which were further evaluated for their inhibitions on oxidative stress and inflammation using NAD(P)H:quinone reductase (QR) assay and nitric oxide (NO) production assay. Of these ingredients, 3-methoxy-5-pentyl-phenol (MPP, 5) was identified as an Nrf2 activator and an NF-κB inhibitor. Further studies demonstrated the following: (i) MPP upregulated the protein levels of Nrf2, NAD(P)H:quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase regulatory subunit (GCLM); enhanced the nuclear translocation and stabilization of Nrf2; and inhibited arsenic [As(III)]-induced oxidative insult in normal human lung epithelial Beas-2B cells. And (ii) MPP suppressed the nuclear translocation of NF-κB p65 subunit; inhibited the lipopolysaccharide- (LPS-) stimulated increases of NF-κB p65 subunit, COX-2, iNOS, TNF-α, and IL-1ß; and blocked the LPS-induced biodegrade of IκB-α in RAW 264.7 murine macrophages. Taken together, MPP displayed potential preventive effects against inflammation- and oxidative stress-related diseases.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Bronchi/pathology , Epithelial Cells/drug effects , Inflammation/drug therapy , Oxidative Stress/drug effects , Phenols/therapeutic use , Plant Extracts/therapeutic use , Animals , Anti-Inflammatory Agents/chemistry , Epithelial Cells/physiology , Ethanol/chemistry , Gene Expression Regulation , Humans , Interleukin-1beta/metabolism , Litsea/immunology , Mice , NF-E2-Related Factor 2/metabolism , NF-kappa B/metabolism , Nitric Oxide/metabolism , Phenols/chemistry , Plant Extracts/chemistry , Quinone Reductases/metabolism , RAW 264.7 Cells , Tumor Necrosis Factor-alpha/metabolism
7.
Biol Reprod ; 97(4): 598-611, 2017 Oct 01.
Article in English | MEDLINE | ID: mdl-29025057

ABSTRACT

NRH: quinone oxidoreductase 2 (NQO2) is a cytosolic and ubiquitously expressed flavoprotein that catalyzes the two-electron reduction of quinone to hydroquinones. Herein, we assessed the protein expression, subcellular localization, and possible functions of NQO2 in mouse oocyte meiotic maturation and embryo development. Western blot analysis detected high and stable protein expression of NQO2 in mouse oocytes during meiotic progression. Immunofluorescence illustrated NQO2 distribution on nuclear membrane, chromosomes, and meiotic spindles. Microtubule poisons treatment (nocodazole and taxol) showed that filamentous assembly of NQO2 and its co-localization with microtubules require microtubule integrity and normal dynamics. Increased levels of NQO2, reactive oxygen species (ROS), malondialdehyde (MDA), and autophagy protein Beclin1 expression were detected in oocytes cultured with ROS stimulator vitamin K3 (VK3), combined with decreased antioxidant glutathione (GSH). These oocytes were arrested at metaphase I with abnormal spindle structure and chromosome configuration. However, this impact was counteracted by melatonin or NQO2 inhibitor S29434, and the spindle configuration and first polar body extrusion were restored. Similarly, morpholino oligo-induced NQO2 knockdown suppressed ROS, MDA, and Beclin1, instead increased GSH in oocytes under VK3. Supplementary S29434 or melatonin limited changes in NQO2, ROS, MDA, Beclin1, and GSH during in vitro aging of ovulated oocytes, thereby maintaining spindle structure, as well as ordered chromosome separation and embryo development potential after parthenogenetic activation with SrCl2. Taken together, NQO2 is involved in ROS generation and subsequent cytotoxicity in oocytes, and its inhibition can restore oocyte maturation and embryo development, suggesting NQO2 as a pharmacological target for infertility cure.


Subject(s)
Oocytes/physiology , Protein Transport/physiology , Quinone Reductases/metabolism , Reactive Oxygen Species/metabolism , Animals , Antifibrinolytic Agents/pharmacology , Beclin-1/metabolism , Embryo, Mammalian/drug effects , Embryo, Mammalian/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Malondialdehyde/metabolism , Meiosis , Melatonin/pharmacology , Mice , Nocodazole/pharmacology , Oocytes/drug effects , Oocytes/enzymology , Paclitaxel/pharmacology , Parthenogenesis , Pyridines/pharmacology , Pyrrolizidine Alkaloids/pharmacology , Quinone Reductases/antagonists & inhibitors , Quinone Reductases/genetics , Tubulin Modulators/pharmacology , Vitamin K 3/pharmacology
8.
Fitoterapia ; 109: 1-7, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26656409

ABSTRACT

Two new ent-prenylaromadendrane-type diterpenoids, diplotaxifols A (1) and B (2), a new ent-eudesmol, ent-eudesma-4(15),11(13)-dien-6α,12-diol (3), eight new eudesmanolides enantiomers (4-11) of the corresponding compounds from higher plants along with four known ent-eudesmanolides (12-15) were isolated from the 95% EtOH extract of Chinese liverwort Diplophyllum taxifolium. Their structures were elucidated on the basis of MS, NMR and IR spectral data, and confirmed by single-crystal X-ray diffraction analysis. The quinone reductase-inducing activity of the compounds was evaluated.


Subject(s)
Diterpenes/chemistry , Hepatophyta/chemistry , Terpenes/chemistry , Animals , Cell Line, Tumor , Crystallography, X-Ray , Diterpenes/isolation & purification , Mice , Molecular Structure , Phytochemicals/chemistry , Phytochemicals/isolation & purification , Quinone Reductases/metabolism , Terpenes/isolation & purification
9.
Bull Exp Biol Med ; 159(1): 44-7, 2015 May.
Article in English | MEDLINE | ID: mdl-26033588

ABSTRACT

Cell damage depending on activity of quinone reductase 2 (MT3 receptor) was simulated in experiments on bone marrow cell suspension and assessed by menadione-induced DNA breaks measured by comet assay. We analyzed the protective effect of afobazole interacting with MT1, MT3, σ1 receptors, and monoamine oxidase A and its main metabolite M11 that specifi cally binds to MT3 receptors. Both compounds reduced the level of menadione-induced DNA damage (afobazole was effective in lower concentrations in comparison with M-11). Conclusion was made on the contribution of MT3 receptors to the protective effect of afobazole, but the observed concentration differences indicate possible contribution of other targets of anxiolytic drug to the protective mechanisms.


Subject(s)
Anti-Anxiety Agents/pharmacology , Benzimidazoles/pharmacology , Bone Marrow Cells/drug effects , DNA Breaks/drug effects , Morpholines/pharmacology , Neuroprotective Agents/pharmacology , Quinone Reductases/antagonists & inhibitors , Receptors, Melatonin/drug effects , Animals , Anti-Anxiety Agents/metabolism , Benzimidazoles/metabolism , Biotransformation , Cells, Cultured , Comet Assay , Dicumarol/pharmacology , Drug Evaluation, Preclinical , Metallothionein 3 , Mice , Monoamine Oxidase , Monoamine Oxidase Inhibitors , Morpholines/metabolism , NAD(P)H Dehydrogenase (Quinone)/antagonists & inhibitors , Neuroprotective Agents/metabolism , Quinone Reductases/metabolism , Receptor, Melatonin, MT1/drug effects , Receptors, sigma/drug effects , Vitamin K 3/toxicity
10.
Water Sci Technol ; 71(9): 1293-300, 2015.
Article in English | MEDLINE | ID: mdl-25945844

ABSTRACT

The present study was aimed towards the effective bio-treatment of actual industrial effluent containing as high as 42,000 mg/L COD (chemical oxygen demand), >28,000 ADMI (American Dye Manufacturers Institute) color value and four heavy metals using indigenous developed bacterial consortium TSR. Mineral salt medium supplemented with as low as 0.02% (w/v) yeast extract and glucose was found to remove 70% ADMI, 69% COD and >99% sorption of heavy metals in 24 h from the effluent by consortium TSR. The biodegradation of effluent was monitored by UV-vis light, HPLC (high performance liquid chromatography), HPTLC (high performance thin layer chromotography) and FTIR (Fourier transform infrared spectroscopy) and showed significant differences in spectra of untreated and treated effluent, confirming degradation of the effluent. Induction of intracellular azoreductase (107%) and NADH-DCIP reductase (128%) in addition to extracellular laccase (489%) indicates the vital role of the consortium TSR in the degradation process. Toxicity study of the effluent using Allium cepa by single cell gel electrophoresis showed detoxification of the effluent. Ninety per cent germination of plant seeds, Triticum aestivum and Phaseolus mungo, was achieved after treatment by consortium TSR in contrast to only 20% and 30% germination of the respective plants in case of untreated effluent.


Subject(s)
Coloring Agents/isolation & purification , Metals, Heavy/isolation & purification , Microbial Consortia , Waste Disposal, Fluid/methods , Biodegradation, Environmental , Biological Oxygen Demand Analysis , Chromatography, High Pressure Liquid , Industrial Waste/adverse effects , Laccase/metabolism , Phaseolus , Quinone Reductases/metabolism , Spectroscopy, Fourier Transform Infrared , Triticum
11.
J Med Food ; 18(2): 182-9, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25602788

ABSTRACT

In this study, we investigated the hepatoprotective effects of ethanol extracts from Chlorella vulgaris (CH) on animals. We measured its effect on the quinone reductase (QR) activity in Hepa1c1c7 cells, finding that CH induced a significantly higher QR activity in these cells. We isolated the active fraction (CH F4-2) from CH using chromatography methods. CH F4-2 may activate cellular antioxidant enzymes through upregulation of the Nrf2 pathway in hepatocarcinoma cells with CH F4-2 (25.0-200 µg/mL) for 48 h. Furthermore, CH F4-2 increased the expression of NQO1 [ NAD(P)H: quinone oxidoreductase, also known as QR], heme oxygenase-1, and glutathione-S-transferase P. Moreover, we found that ethanol-induced hepatic pathological changes-elevations in glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, γ-glutamyltransferase, and lactate dehydrogenase-were significantly decreased. The inhibitory effect of CH on alcohol-induced liver injury was associated with the suppression of alcohol-induced increases in intestinal permeability. The ethanol extract from CH was found to induce QR activation, making it a potentially good candidate for a hepatoprotection agent.


Subject(s)
Chemical and Drug Induced Liver Injury , Chlorella vulgaris , Ethanol , NF-E2-Related Factor 2 , Phytotherapy , Plant Extracts , Animals , Male , Rats , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Chemical and Drug Induced Liver Injury/drug therapy , Chemical and Drug Induced Liver Injury/enzymology , Chlorella vulgaris/chemistry , Ethanol/toxicity , gamma-Glutamyltransferase/blood , L-Lactate Dehydrogenase/blood , Liver/cytology , Liver/metabolism , Liver/pathology , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms, Experimental/metabolism , NAD(P)H Dehydrogenase (Quinone)/drug effects , NAD(P)H Dehydrogenase (Quinone)/metabolism , NF-E2-Related Factor 2/drug effects , NF-E2-Related Factor 2/metabolism , Plant Extracts/pharmacology , Quinone Reductases/drug effects , Quinone Reductases/metabolism , Rats, Sprague-Dawley , Up-Regulation/drug effects
12.
Arch Pharm Res ; 36(4): 430-5, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23440579

ABSTRACT

The purpose of this study is to define the antimalarial activity of Rumex crispus. To identify an active compound that is isolated from R. crispus, bioassay-based chromatographic fractionation and purification is carried out from 70 % ethanol extract of R. crispus; then, an active compound, nepodin, is identified by spectroscopic analysis. Anitmalarial activity is measured by PfNDH2 assay, cytotoxicity, and animal test. From NADH:quinone oxidoreductase enzyme (PfNDAH2) assay, nepodin exhibited significant IC50 values that were 0.74 ± 0.07 and 0.79 ± 0.06 µg/ml against P. falciparum chloroquine-sensitive (3D7) and P. falciparum chloroquine-resistant (S20), respectively. Nepodin showed a potential selective inhibition (SI index: ratio of 50 % cytotoxic concentration to 50 % effective anti-plasmodial concentration) of 161.6 and 151.4 against P. falciparum 3D7 and P. falciparum S20. In the animal test, all groups of nepodin treatment of 10, 50, and 250 mg/kg were active with a parasitemia suppression of 97.1 ± 3.3, 99.1 ± 3.7, and 99.1 ± 2.6 %, respectively. The survival time with nepodin treatment was increased by 14.6 ± 2.5, 16.2 ± 1.5, and 19.8 ± 1.7 days at each dose, respectively. This study newly identified the plant R. crispus containing nepodin, which is a potential antimalarial compound. It exhibited the inhibitory activity of PfNDH2 and prolonged the survival time on the group of nepodin treatment; moreover, it inhibited the parasitemia in the animal test.


Subject(s)
Antimalarials/pharmacology , Malaria, Falciparum/drug therapy , Naphthalenes/pharmacology , Plant Extracts/pharmacology , Plasmodium falciparum/drug effects , Rumex , Animals , Antimalarials/chemistry , Antimalarials/isolation & purification , Antimalarials/toxicity , Chemical Fractionation , Chlorocebus aethiops , Disease Models, Animal , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/isolation & purification , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/toxicity , Malaria, Falciparum/parasitology , Male , Mice , Mice, Inbred C57BL , Naphthalenes/chemistry , Naphthalenes/isolation & purification , Naphthalenes/toxicity , Phytotherapy , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/toxicity , Plants, Medicinal , Plasmodium falciparum/growth & development , Quinone Reductases/antagonists & inhibitors , Quinone Reductases/metabolism , Rumex/chemistry , Solvents/chemistry , Time Factors , Vero Cells
13.
Eur J Nutr ; 52(3): 1279-85, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22710810

ABSTRACT

PURPOSE: Glucosinolates/isothiocyanates are an established class of naturally occurring chemopreventive agents, a principal mechanism of action being to limit the generation of genotoxic metabolites of chemical carcinogens, as a result of modulation of cytochrome P450 and phase II detoxification enzymes. The objective of this study was to assess whether a glucosinolate-rich extract from Daikon sprouts, containing glucroraphasatin and glucoraphenin, is a potential chemopreventive agent by modulating such enzymes in the liver and lung of rats. METHODS: Rats were exposed to the glucosinolate-rich Daikon extract through the diet, at three dose levels, for 14 days, so that the low dose simulates dietary intake. RESULTS: At the low dose only, a modest increase was noted in the hepatic dealkylations of methoxy-, ethoxy-, pentoxyresorufin and benzyloxyquinoline that was accompanied by elevated expression of CYP1 and CYP3A2 apoprotein levels. In lung, only a modest increase in the dealkylation of pentoxyresorufin was observed. At higher doses, in both tissues, these increases were abolished. At the same low dietary dose, the Daikon extract elevated markedly glutathione S-transferase activity paralleled by rises in GSTα, GSTµ and GSTπ protein expression. An increase was also noted in quinone reductase activity and expression. Finally, glucuronosyl transferase and epoxide hydrolase activities and expression were also up-regulated, but necessitated higher doses. CONCLUSION: Considering the ability of Daikon glucosinolates to effectively enhance detoxification enzymes, in particular glutathione S-transferase, it may be inferred that consumption of this vegetable may possess significant chemopreventive activity and warrants further evaluation through epidemiology and studies in animal models of cancer.


Subject(s)
Anticarcinogenic Agents/metabolism , Dietary Supplements , Glucosinolates/metabolism , Glutathione Transferase/biosynthesis , Liver/enzymology , Plant Extracts/metabolism , Raphanus/chemistry , Animals , Anticarcinogenic Agents/administration & dosage , Carcinogens/metabolism , Cytochrome P-450 Enzyme System/biosynthesis , Cytochrome P-450 Enzyme System/metabolism , Enzyme Induction , Epoxide Hydrolases/biosynthesis , Epoxide Hydrolases/metabolism , Glucosinolates/administration & dosage , Glucuronosyltransferase/biosynthesis , Glucuronosyltransferase/metabolism , Glutathione Transferase/metabolism , Isoenzymes/biosynthesis , Isoenzymes/metabolism , Liver/metabolism , Male , Plant Extracts/administration & dosage , Plant Shoots/chemistry , Quinone Reductases/biosynthesis , Quinone Reductases/metabolism , Random Allocation , Rats , Rats, Wistar
14.
Reprod Biol Endocrinol ; 10: 103, 2012 Dec 03.
Article in English | MEDLINE | ID: mdl-23207065

ABSTRACT

BACKGROUND: Melatonin inclusion into in vitro oocyte maturation (IVM) protocols has been suggested because it possesses a powerful free radical scavenger capability that improves the quality of the oocyte used in in vitro embryo production (IVP). The aim of our study was to investigate the presence of melatonin membrane receptors (MT1and MT2) and MT3, which is the melatonin binding site of NQO2 enzyme, in both oocytes and hatched blastocysts to consider an additional subcellular mechanism responsible for the effects of melatonin on IVP. METHODS: The presence of the high affinity melatonin receptors was investigated through an autoradiographic binding assay, using the non-permeable ligand [125I]-iodomelatonin (17 pM) in embryos. The kind of melatonin site was investigated in oocytes and embryos by immunocytochemistry. In vitro fertilized bovine embryos produced from in vitro maturated oocytes supplemented with melatonin (0.0001 to 1000 nM) were analysed to determine their cleavage and blastocyst formation rates. RESULTS: The [125I]-iodomelatonin (17 pM) binding in blastocysts was blocked by pre-incubation with melatonin (30000 nM), showing the presence of the high affinity melatonin receptors. MT1, MT2 and NQO2 immunoreactivity was observed in oocytes. MT1 immunoreactivity was observed in hatched blastocysts, however MT2 and NQO2 were not observed in this embryonic stage. Melatonin (pM) triggered significant difference in both cleavage and blastocysts formation rates. CONCLUSIONS: The high affinity MT1 melatonin receptor must be taking part in IVM events; furthermore it is the first melatonin receptor to appear during bovine embryo development in vitro.


Subject(s)
Blastocyst/metabolism , Cattle/embryology , Oocytes/metabolism , Receptor, Melatonin, MT1/metabolism , Receptor, Melatonin, MT2/metabolism , Receptors, Melatonin/metabolism , Animals , Antioxidants/pharmacology , Blastocyst/drug effects , Embryo Culture Techniques , Female , Fertilization in Vitro/veterinary , Melatonin/pharmacology , Oocytes/drug effects , Quinone Reductases/metabolism
15.
Fitoterapia ; 83(8): 1506-13, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22960348

ABSTRACT

In the present study, it was demonstrated that the petroleum extract of Andrographis paniculata (AP) had quinone reductase (QR) inducing activity, which might be attributed to the modification of key cysteine residues in Keap1 by Michael addition acceptors (MAAs) in it. To screen MAAs in AP, glutathione (GSH) was employed, and a LC/MS/MS method was implied. Three compounds, andrographoside, andrographolide, 14-deoxy-14,15-dehydroandrographolide were revealed could well conjugated with GSH. Then, andrographolide along with 4 new and 14 known compounds were isolated to conduct QR induction evaluation, and the CD (the concentration required to double the activity of QR) value of andrographolide is 1.43µM. The QR induce activity of andrographolide might be attributed to its targeting multiple cysteine residues in Keap1, therefore, the alkylation of Keap1 by andrographolide was further studied and the result showed that four cysteine residues: Cys77, Cys151, Cys273 and Cys368 were alkylated, which indicated that Keap1 is a potential target for the QR induce activity of andrographolide.


Subject(s)
Andrographis/chemistry , Diterpenes/pharmacology , Quinone Reductases/metabolism , Cell Line , Diterpenes/chemistry , Enzyme Activation , Gene Expression Regulation , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Kelch-Like ECH-Associated Protein 1 , Molecular Structure , Plant Extracts/chemistry , Quinone Reductases/genetics , Recombinant Proteins
16.
Fitoterapia ; 83(2): 281-5, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22119764

ABSTRACT

The ethylacetate and n-butanol fractions of ethanolic extract of Platanus orientalis leaves led to the isolation of new acylated flavonol glycoside as 3',5,7-trihydroxy-4'-methoxyflavonol 3-[O-2-O-(2,4-Dihydroxy)-E-cinnamoyl-α-L-rhamnopyranosyl-(1→6)-ß-D-glucopyranosyl (1→2)]-ß-D-glucopyranoside, along with seven known compounds. All the compounds were characterized by NMR including 2D NMR techniques. The isolates were evaluated for NF-κB, nitric oxide (NO), aromatase and QR2 chemoprevention activities and some of them appeared to be modestly active.


Subject(s)
Flavonols/pharmacology , Glycosides/pharmacology , Magnoliopsida/chemistry , Plant Extracts/pharmacology , Acylation , Aromatase/metabolism , Cell Line , Chemoprevention , Female , Flavonols/chemistry , Flavonols/isolation & purification , Glycosides/chemistry , Glycosides/isolation & purification , Humans , Magnetic Resonance Spectroscopy , Molecular Structure , NF-kappa B/metabolism , Nitric Oxide/metabolism , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Plants, Medicinal/chemistry , Quinone Reductases/antagonists & inhibitors , Quinone Reductases/metabolism
17.
Hum Exp Toxicol ; 30(1): 55-62, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20354059

ABSTRACT

In this study, the in vivo antioxidant potentials of Piliostigma thonningii were investigated in carbon tetrachloride-induced hepatic and oxidative damage in rat. Albino rats were grouped into six, group A rats received sterile distilled water for 14 days while B rats received 0.5 mL/kg body weight of carbon tetrachloride intraperitoneally on day 14. Group C rats received 200 mg/kg body weight of Piliostigma thonningii leaves extract for 14 days. Groups D, E and F rats were pretreated with 50, 100 and 200 mg/kg body weight of Piliostigma thonningii leaves for 14 days and challenged with 0.5 mL/kg body weight of carbon tetrachloride on day 14. The extract treatment significantly attenuated both the decrease and the increase in liver and serum marker enzyme. Antioxidant enzyme activity as well as level of uridyl diphosphoglucuronosyl transferase, quinone oxidoreductase and glutathione S-transferase was significantly induced. There was attenuation of malonidialdehyde and lipid hydroperoxide increase. On the basis of the available data in this report, it can be postulated that Piliostigma thonningii leaves protect liver against hepatic and oxidative damage by carbon tetrachloride possibly by acting as an in vivo free radical scavenger, induction of antioxidant enzymes, drug detoxifying enzymes and prevention of excessive stimulation of antioxidant enzyme and lipid peroxidation.


Subject(s)
Antioxidants/therapeutic use , Chemical and Drug Induced Liver Injury/prevention & control , Fabaceae/chemistry , Inactivation, Metabolic , Lipid Peroxidation/drug effects , Phytotherapy , Plant Extracts/therapeutic use , Animals , Antioxidants/administration & dosage , Biomarkers/blood , Carbon Tetrachloride Poisoning/drug therapy , Chemical and Drug Induced Liver Injury/blood , Chemical and Drug Induced Liver Injury/metabolism , Dose-Response Relationship, Drug , Glucuronosyltransferase/metabolism , Glutathione Transferase/metabolism , Lipid Peroxides/metabolism , Male , Malondialdehyde/metabolism , Plant Extracts/administration & dosage , Plant Leaves/chemistry , Quinone Reductases/metabolism , Random Allocation , Rats
18.
Pharmacol Res ; 63(1): 68-76, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20969959

ABSTRACT

Hydrogen sulfide (H(2)S) is a new gasotransmitter synthesized enzymatically from l-cysteine in cytosol and is oxidized in mitochondria. In the cardiovascular system, H(2)S regulates vascular tone, inhibits atherogenesis, and protects against myocardial ischemia-reperfusion injury. We examined the effect of statins on vascular H(2)S production. Male Wistar rats received pravastatin (40mg/kg/day) or atorvastatin (20mg/kg/day) for 3 weeks and then H(2)S formation was measured in aortic media, periaortic adipose tissue (PAAT) and the liver. Only atorvastatin increased H(2)S production in PAAT whereas both statins stimulated its formation in the liver. Neither statin affected H(2)S production in aortic media. H(2)S formation in post-mitochondrial supernatant was higher than in mitochondria-containing supernatant and was not influenced by statins in any tissue. In addition, oxidation of exogenous H(2)S in isolated liver mitochondria was slower in statin-treated than in control rats. These data indicate that statins increase net H(2)S production by inhibiting its mitochondrial oxidation. Statins had no effect on the activity of H(2)S-metabolizing enzyme, sulfide:quinone oxidoreductase, measured at saturating coenzyme Q concentration. Both statins reduced CoQ(9) concentration in plasma and liver, but only atorvastatin decreased CoQ(9) in PAAT. Atorvastatin attenuated phenylephrine-induced contraction of PAAT+ but not of PAAT- aortic rings. Effects of atorvastatin on net H(2)S production, mitochondrial H(2)S oxidation and aortic contractility were abolished by supplementation of exogenous CoQ(9). In conclusion, lipophilic atorvastatin, but not hydrophilic pravastatin, increases net H(2)S production in perivascular adipose tissue by inhibiting its mitochondrial oxidation. This effect is mediated by statin-induced CoQ(9) deficiency and results in the augmentation of anticontractile effect of perivascular adipose tissue.


Subject(s)
Adipose Tissue/drug effects , Aorta, Thoracic/drug effects , Heptanoic Acids/pharmacology , Hydrogen Sulfide/metabolism , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Pravastatin/pharmacology , Pyrroles/pharmacology , Vasodilation/drug effects , Adipose Tissue/metabolism , Animals , Aorta, Thoracic/metabolism , Atorvastatin , Cholesterol/blood , Cholesterol, HDL/blood , Dose-Response Relationship, Drug , KATP Channels/drug effects , KATP Channels/metabolism , Liver/drug effects , Liver/metabolism , Male , Mitochondria, Liver/drug effects , Mitochondria, Liver/metabolism , Oxidation-Reduction , Potassium Channel Blockers/pharmacology , Quinone Reductases/metabolism , Rats , Rats, Wistar , Sulfides/metabolism , Triglycerides/blood , Ubiquinone/analogs & derivatives , Ubiquinone/metabolism , Vasoconstrictor Agents/pharmacology
19.
J Food Sci ; 75(6): H190-9, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-20722931

ABSTRACT

In cruciferous vegetables, myrosinase metabolizes the relatively inactive glucosinolates into isothiocyanates and other products that have the ability to increase detoxification enzyme expression. Thus, maintaining myrosinase activity during food preparation may be critical to receiving the maximum benefit of consumption of Brussels sprouts or other cruciferous vegetables. To test the importance of maintaining myrosinase activity for maximizing bioactivity, experimental diets containing 20% unblanched (active myrosinase) or 20% blanched (inactivated myrosinase) freeze-dried Brussels sprouts and a nutrient-matched control diet were evaluated in vitro and in vivo for their ability to induce detoxification enzymes. Treatment of immortalized HepG2 human hepatoma cells with the unblanched Brussels sprout diet caused a greater increase quinone activity compared to the blanched Brussels sprout diet. C3H/HeJ mice fed the unblanched Brussels sprout diets for 2 wk had significantly higher plasma sulforaphane concentrations. Liver expression of CYP1A1 and epoxide hydrolase, measured using real-time PCR, was correlated with the plasma concentration of sulforaphane. In the lung, expression of epoxide hydrolase, thioredoxin reductase, UDP glucuronosyltransferase, quinone reductase, heme oxygenase, CYP1A1, CYP1A2, and CYP1B1 were also correlated with the plasma concentration of sulforaphane. Together these data demonstrate that, as predicted by the in vitro experiment, in vivo exposure to Brussels sprouts with active myrosinase resulted in greater induction of both phase I and phase II detoxification enzymes in the liver and the lungs that correlated with plasma sulforaphane concentrations.


Subject(s)
Brassica , Gene Expression Regulation, Enzymologic , Glycoside Hydrolases/metabolism , Liver/enzymology , Lung/enzymology , Plant Proteins, Dietary/metabolism , Thiocyanates/blood , Animals , Brassica/chemistry , Brassica/enzymology , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP1A1/metabolism , Enzyme Induction , Epoxide Hydrolases/genetics , Epoxide Hydrolases/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Glucosinolates/analysis , Glucosinolates/metabolism , Hep G2 Cells , Hot Temperature , Humans , Inactivation, Metabolic , Isothiocyanates/analysis , Liver/drug effects , Male , Mice , Mice, Inbred C3H , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Leaves/chemistry , Plant Leaves/enzymology , Quinone Reductases/genetics , Quinone Reductases/metabolism , RNA, Messenger/metabolism , Sulfoxides , Thiocyanates/metabolism
20.
Planta Med ; 74(11): 1387-90, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18729042

ABSTRACT

Rutaecarpine is a quinazolinocarboline alkaloid isolated from Evodia rutaecarpa (Juss.), which has been used in traditional Chinese medicine. The bioactivity-guided fractionation has led to the isolation of rutaecarpine from the extract of the fruits of E. rutaecarpa as the major component possessing NAD(P)H:quinone reductase (QR) activity. The activator protein-1 (AP-1), a transcriptional factor, in the antioxidant response element (ARE) region plays an important role in mediating induction of the target genes by xenobiotics, including chemopreventive agents. The present study demonstrates that rutaecarpine induces QR activity and gene expression by transactivation of AP-1. To study the induction of QR activity and AP-1-mediated QR gene expression by rutaecarpine, we performed enzyme and reporter gene assays. This compound markedly induced the enzyme activity and mRNA expression levels of QR in a dose-dependent manner. Using the luciferase reporter gene assay, a dose-dependent transactivation of AP-1-mediated luciferase expression was observed upon treatment of rutaecarpine. These results suggest that rutaecarpine induces QR gene expression and activity through an increase in AP-1 activation.


Subject(s)
Evodia/chemistry , Indole Alkaloids/pharmacology , Quinazolines/pharmacology , Quinone Reductases/metabolism , Animals , Cell Line, Tumor , Chemoprevention , Fruit/chemistry , Indole Alkaloids/isolation & purification , Mice , Plant Extracts/pharmacology , Quinazolines/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL